|
|
|
09157
|
|
|
P.I.:
|
Mihaela Cristea, MD
|
(Cooperative Group)
|
|
Title:
|
SWOG; S0720: Phase II ERCC1 and RRM1-Based Adjuvant Therapy Trial in Patients with Stage I Non-Small Lung Cancer (NSCLC)
|
| | |
|
|
08187
|
|
|
P.I.:
|
Mihaela Cristea, MD
|
(Cooperative Group)
|
|
Title:
|
GOG-0076GG: A Limited Access Phase II Trial of Pemetrexed (Alimta, LY231514) (NSC #698037) in Combination with Cisplatin (NSC #119875) in the Treatment of Advanced, Persistent, or Recurrent Carcinoma of the Cervix
|
| | |
|
|
08059
|
|
|
P.I.:
|
Mihaela Cristea, MD
|
(Institutional)
|
|
Title:
|
Phase I Trial of Intraperitoneal nab-Paclitaxel (Abraxane) in the Treatment of Advanced Malignancies Primarily Confined to the Peritoneal Cavity
|
| | |
|
|
07187
|
|
|
P.I.:
|
Mihaela Cristea, MD
|
(Institutional)
|
|
Title:
|
Evaluation of Ovarian Cancer and Outcomes of Care
|
|
|
06002
|
|
|
P.I.:
|
Mihaela Cristea, MD
|
(Cooperative Group)
|
|
Title:
|
SWOG S0424: Molecular Epidemiology Case-Series Study of NSCLC in Smoking and Non-Smoking Women and Men
|
| | |
|